NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
Clinical Trials
3 trialsNCT02804945 2020-04-10
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00141726 2015-12-03
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
University of Michigan Rogel Cancer Center
Phase 2 Completed